Difesa Capital Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Difesa Capital Management’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-432,148	Closed	-$1.14M	–	276
2022 Q3	$1.14M	Buy	432,148 +264,748	+158%	+$390K	0.58%	51
2022 Q2	$114K	Hold	167,400	–	–	0.07%	113
2022 Q1	$264K	Buy	167,400 +67,400	+67%	+$97.1K	0.13%	110
2021 Q4	$239K	Buy	+100,000	New	+$303K	0.16%	106

Other funds holding CANO.WS

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Difesa Capital Management's CANO.WS Position: Q4 2022 in Review

Difesa Capital Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2022, closing a stake of 432,148 shares — an estimated $1.14M sold.

Difesa Capital Management first reported a position in CANO.WS in Q4 2021 and held it in 4 quarters. The position peaked at $1.14M in Q3 2022. 27 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2022.

Difesa Capital Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2022 after selling out during the quarter.
Difesa Capital Management sold 432,148 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2022, an estimated $1.14M.
Difesa Capital Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q4 2021 and held it in 4 quarters.
Difesa Capital Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $1.14M in Q3 2022.
27 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2022.

Based on Difesa Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.